CBAY

Why is CymaBay (CBAY) Stock Up 25% Today?

By William White, InvestorPlace Writer
CymaBay stock is rising higher on Monday as CBAY investors react to a $4.3 billion acquisition deal with Gilead Sciences.

7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio

By Josh Enomoto, InvestorPlace Contributor
Dive into these seven strong buy biotech stocks, handpicked by Wall Street, to inject vigor into your investment game.

7 Penny Stocks With the Potential to 10X in 2022

By Chris Markoch, InvestorPlace Contributor
The broader market looks expensive, but these penny stocks provide low-cost opportunities for considerable upside according to analysts.

7 Disruptive Biotech Stocks to Buy for 2025

By Harriet Lefton, Writer, TipRanks
RBC Capital has peered into its crystal ball to reveal some of the market's most exciting biotech stocks. Here are seven that stand out.

7 Stocks the Insiders Are Buying on Sale

By Mark Putrino, CMT
Insiders sell stocks for many reasons, but the only reason they buy is that they believe they will profit. Check out these insider buying picks.

Oppenheimer’s 7 Top Stock Picks for September

By Harriet Lefton, Writer, TipRanks
Are you looking for a post-summer portfolio boost? Look no further. Oppenheimer bank has just released a bullish report highlighting its Top Stock Picks.

7 ‘Strong Buy’ Disruptive Stocks You Should Track Now

By Harriet Lefton, Writer, TipRanks
These 7 "Strong Buy" stocks are all innovative disruptors in their fields with a bullish outlook from the Street's best analysts.

Intercept Pharmaceuticals Inc (ICPT) Stock Dives on Drug Warning

By William White, InvestorPlace Writer
Intercept Pharmaceuticals (ICPT) stock took a hit on Tuesday following the release of a drug warning concerning its Ocaliva.